BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Biotech Bay

  Vir Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference

  Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Bolyn Hubby, Ph.D., Executive Vice President and Chief Corporate Affairs Officer, will participate in a panel focused on infectious diseases at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, at 6:10 a.m. PT / 9:10 a.m. ET.

  February 28, 2023

   · 

  1 min read
• Pharm Country

  Verrica Pharmaceuticals Announces Participation at The Cowen 43rd Annual Health Care Conference

  Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA) today announced Ted White, Verrica President and CEO, will participate in a fireside chat at The Cowen 43rd Annual Health Care Conference, taking place from March 6 - 8, 2023, in Boston, MA.

  February 28, 2023

   · 

  2 min read
• Biotech Bay

  CytomX Therapeutics to Present at Upcoming March 2023 Investor Conferences

  CytomX Therapeutics, Inc., a leader in the field of conditionally activated, localized biologics, announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor conferences in March.

  February 28, 2023

   · 

  2 min read
• Business

  NGM Bio Provides Business Highlights and Reports Fourth Quarter and Full Year 2022 Financial Results

  NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today provided business highlights and reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 28, 2023

   · 

  11 min read
• BioMidwest

  Cumberland Pharmaceuticals to Announce Annual 2022 Financial Results

  Cumberland Pharmaceuticals Inc., a specialty pharmaceuticals company, announced that it will release its annual 2022 financial results and provide a company update after the market closes on Tuesday, March 7, 2023.

  February 28, 2023

   · 

  2 min read
• Business

  Revance Adds Experienced Pharmaceutical Executive to Board of Directors with Appointment of Dr. Vlad Coric, M.D., as Independent Director

  Revance Therapeutics, Inc., announced the appointment of Dr. Vlad Coric, M.D., to its Board of Directors, effective March 1, 2023.

  February 28, 2023

   · 

  8 min read
• Business

  Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

  Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported financial results for the fourth quarter and full year ended December 31, 2022.

  February 28, 2023

   · 

  13 min read
• Policy

  FDA Roundup: February 28, 2023

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

  February 28, 2023

   · 

  6 min read
• Business

  Agilent Reports First-Quarter Fiscal Year 2023 Financial Results

  Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a core(1) basis.

  February 28, 2023

   · 

  18 min read
• Business

  Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments

  Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the fourth quarter and full-year 2022.

  February 28, 2023

   · 

  39 min read